Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type I.

Molecular Genetics and Metabolism
Patricia I DicksonN Matthew Ellinwood

Abstract

Enzyme replacement therapy (ERT) with intravenous recombinant human alpha-l-iduronidase (IV rhIDU) is a treatment for patients with mucopolysaccharidosis I (MPS I). Spinal cord compression develops in MPS I patients due in part to dural and leptomeningeal thickening from accumulated glycosaminoglycans (GAG). We tested long-term and every 3-month intrathecal (IT) and weekly IV rhIDU in MPS I dogs age 12-15months (Adult) and MPS I pups age 2-23days (Early) to determine whether spinal cord compression could be reversed, stabilized, or prevented. Five treatment groups of MPS I dogs were evaluated (n=4 per group): IT+IV Adult, IV Adult, IT + IV Early, 0.58mg/kg IV Early and 1.57mg/kg IV Early. IT + IV rhIDU (Adult and Early) led to very high iduronidase levels in cervical, thoracic, and lumber spinal meninges (3600-29,000% of normal), while IV rhIDU alone (Adult and Early) led to levels that were 8.2-176% of normal. GAG storage was significantly reduced from untreated levels in spinal meninges of IT + IV Early (p<.001), IT+IV Adult (p=.001), 0.58mg/kg IV Early (p=.002) and 1.57mg/kg IV Early (p<.001) treatment groups. Treatment of dogs shortly after birth with IT+IV rhIDU (IT + IV Early) led to normal to near-normal GAG levels in th...Continue Reading

References

Jun 1, 1982·Surgical Neurology·H H KaufmanI J Butler
Jan 13, 2004·Proceedings of the National Academy of Sciences of the United States of America·E KakkisM Passage
Apr 13, 2005·Clinical Neurology and Neurosurgery·Melike MutNejat Akalan
Aug 15, 2006·Journal of Developmental and Behavioral Pediatrics : JDBP·Kendra J BjorakerElsa G Shapiro
Feb 27, 2007·Molecular Genetics and Metabolism·Patricia DicksonEmil Kakkis
Aug 19, 2008·Molecular Genetics and Metabolism·Ramin Sedaghat HeratiKatherine P Ponder

❮ Previous
Next ❯

Citations

May 13, 2014·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Yoshiyuki Suzuki
Jul 17, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Christian HindererJames M Wilson
Jan 12, 2012·European Journal of Pediatrics·Kristin D'AcoPaige Kaplan
Jan 11, 2012·Rheumatology·Klane K White
May 18, 2011·Experimental Neurology·Gauthami S KondagariRosanne M Taylor
May 10, 2011·Neurobiology of Disease·Allison C CrawleyKim M Hemsley
Dec 24, 2010·Neuropathology and Applied Neurobiology·R D JollyH Beard
Jul 14, 2011·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Agnes ChenPatricia Dickson
Jul 30, 2014·The European Journal of Neuroscience·Sofia HassiotisKim M Hemsley
Jun 6, 2014·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Joseph A ChiaroLachlan J Smith
May 15, 2015·Molecular Genetics and Metabolism·Heather L Gray-EdwardsDouglas R Martin
Aug 12, 2015·Molecular Genetics and Metabolism·Patricia I DicksonUNKNOWN Mucopolysaccharidosis I Intrathecal Research Collaborative
Jan 15, 2014·Molecular Genetics and Metabolism·Gwen GunnKim M Keeling
Feb 12, 2015·Human Gene Therapy. Clinical Development·Allison M BradburyMark E Haskins
Feb 14, 2015·PloS One·David SatzerWalter C Low
Mar 9, 2011·Laboratory Investigation; a Journal of Technical Methods and Pathology·Jeremiah A LyonsMichael F McEntee
Nov 18, 2018·Italian Journal of Pediatrics·Simona FecarottaGiancarlo Parenti
Jul 18, 2020·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Margaret A McNultyCathy S Carlson
May 19, 2019·Cellular and Molecular Life Sciences : CMLS·Azam SafaryMohammad A Rafi
Mar 29, 2020·Frontiers in Veterinary Science·Brett D StoryHeather L Gray-Edwards
Aug 14, 2020·Journal of Veterinary Internal Medicine·Kiterie M E FallerJose Bras
Mar 4, 2021·Expert Opinion on Biological Therapy·Azam SafaryYadollah Omidi
Sep 5, 2021·Journal of Inherited Metabolic Disease·Sandra D K Kingma, An I Jonckheere

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.